The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review

Patients with the 15q11.2 BP1–BP2 microdeletion can present with developmental and language delay, neurobehavioral disturbances and psychiatric problems. Autism, seizures, schizophrenia and mild dysmorphic features are less commonly seen. The 15q11.2 BP1–BP2 microdeletion involving four genes (i.e.,...

Full description

Bibliographic Details
Main Authors: Devin M. Cox, Merlin G. Butler
Format: Article
Language:English
Published: MDPI AG 2015-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/16/2/4068
id doaj-fc9b98c704f348e8aeeb671bd4feb039
record_format Article
spelling doaj-fc9b98c704f348e8aeeb671bd4feb0392020-11-25T00:52:28ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-02-011624068408210.3390/ijms16024068ijms16024068The 15q11.2 BP1–BP2 Microdeletion Syndrome: A ReviewDevin M. Cox0Merlin G. Butler1Departments of Psychiatry & Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 4015, Kansas City, KS 66160, USADepartments of Psychiatry & Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 4015, Kansas City, KS 66160, USAPatients with the 15q11.2 BP1–BP2 microdeletion can present with developmental and language delay, neurobehavioral disturbances and psychiatric problems. Autism, seizures, schizophrenia and mild dysmorphic features are less commonly seen. The 15q11.2 BP1–BP2 microdeletion involving four genes (i.e., TUBGCP5, CYFIP1, NIPA1, NIPA2) is emerging as a recognized syndrome with a prevalence ranging from 0.57%–1.27% of patients presenting for microarray analysis which is a two to four fold increase compared with controls. Review of clinical features from about 200 individuals were grouped into five categories and included developmental (73%) and speech (67%) delays; dysmorphic ears (46%) and palatal anomalies (46%); writing (60%) and reading (57%) difficulties, memory problems (60%) and verbal IQ scores ≤75 (50%); general behavioral problems, unspecified (55%) and abnormal brain imaging (43%). Other clinical features noted but not considered as common were seizures/epilepsy (26%), autism spectrum disorder (27%), attention deficit disorder (ADD)/attention deficit hyperactivity disorder (ADHD) (35%), schizophrenia/paranoid psychosis (20%) and motor delay (42%). Not all individuals with the deletion are clinically affected, yet the collection of findings appear to share biological pathways and presumed genetic mechanisms. Neuropsychiatric and behavior disturbances and mild dysmorphic features are associated with genomic imbalances of the 15q11.2 BP1–BP2 region, including microdeletions, but with an apparent incomplete penetrance and variable expressivity.http://www.mdpi.com/1422-0067/16/2/406815q11.2 BP1–BP2 microdeletionBurnside-Butler syndromeclinical and behavioral phenotypechromosome breakpoints BP1 and BP2Prader-Willi and Angelman syndromeslanguage and motor delaysautismreview
collection DOAJ
language English
format Article
sources DOAJ
author Devin M. Cox
Merlin G. Butler
spellingShingle Devin M. Cox
Merlin G. Butler
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
International Journal of Molecular Sciences
15q11.2 BP1–BP2 microdeletion
Burnside-Butler syndrome
clinical and behavioral phenotype
chromosome breakpoints BP1 and BP2
Prader-Willi and Angelman syndromes
language and motor delays
autism
review
author_facet Devin M. Cox
Merlin G. Butler
author_sort Devin M. Cox
title The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
title_short The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
title_full The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
title_fullStr The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
title_full_unstemmed The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
title_sort 15q11.2 bp1–bp2 microdeletion syndrome: a review
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2015-02-01
description Patients with the 15q11.2 BP1–BP2 microdeletion can present with developmental and language delay, neurobehavioral disturbances and psychiatric problems. Autism, seizures, schizophrenia and mild dysmorphic features are less commonly seen. The 15q11.2 BP1–BP2 microdeletion involving four genes (i.e., TUBGCP5, CYFIP1, NIPA1, NIPA2) is emerging as a recognized syndrome with a prevalence ranging from 0.57%–1.27% of patients presenting for microarray analysis which is a two to four fold increase compared with controls. Review of clinical features from about 200 individuals were grouped into five categories and included developmental (73%) and speech (67%) delays; dysmorphic ears (46%) and palatal anomalies (46%); writing (60%) and reading (57%) difficulties, memory problems (60%) and verbal IQ scores ≤75 (50%); general behavioral problems, unspecified (55%) and abnormal brain imaging (43%). Other clinical features noted but not considered as common were seizures/epilepsy (26%), autism spectrum disorder (27%), attention deficit disorder (ADD)/attention deficit hyperactivity disorder (ADHD) (35%), schizophrenia/paranoid psychosis (20%) and motor delay (42%). Not all individuals with the deletion are clinically affected, yet the collection of findings appear to share biological pathways and presumed genetic mechanisms. Neuropsychiatric and behavior disturbances and mild dysmorphic features are associated with genomic imbalances of the 15q11.2 BP1–BP2 region, including microdeletions, but with an apparent incomplete penetrance and variable expressivity.
topic 15q11.2 BP1–BP2 microdeletion
Burnside-Butler syndrome
clinical and behavioral phenotype
chromosome breakpoints BP1 and BP2
Prader-Willi and Angelman syndromes
language and motor delays
autism
review
url http://www.mdpi.com/1422-0067/16/2/4068
work_keys_str_mv AT devinmcox the15q112bp1bp2microdeletionsyndromeareview
AT merlingbutler the15q112bp1bp2microdeletionsyndromeareview
AT devinmcox 15q112bp1bp2microdeletionsyndromeareview
AT merlingbutler 15q112bp1bp2microdeletionsyndromeareview
_version_ 1725242297723912192